Skip to main content
. Author manuscript; available in PMC: 2011 Sep 17.
Published in final edited form as: HIV Clin Trials. 2011 May-Jun;12(3):141–150. doi: 10.1310/hct1203-141

Table 3.

Comparison of frequency domain analysis parameters by HIV viremia categories during spontaneous breathing, paced breathing, handgrip, and tilt maneuvers

HIV negative
HIV positive
Control Virologic suppression Virologic nonsuppression All HIV-positive participants
Spontaneous breathing Low-frequency power (nu) 63.3 (51.5, 74.7) 65.2 (50.6, 81.4) 56.4 (50.7, 64.1) 57.0 (51.3, 72.7)
High-frequency power (nu) 36.7 (25.3, 48.5) 34.8 (18.6, 49.5) 43.6 (35.9, 49.3) 43.0 (27.3, 48.7)
Low- to high-frequency power ratio 1.7 (1.1, 3.0) 1.9 (1.0, 4.4) 1.3 (1.0, 1.8) 1.3 (1.1, 2.7)
Paced breathing Low-frequency power (nu) 32.1 (25.0, 38.2) 42.0 (28.0, 53.7) 35.7 (24.0, 39.5) 39.6 (26.4, 52.4)
High-frequency power (nu) 67.9 (61.8, 75.1) 58.0 (46.3, 72.0) 64.3 (60.5, 76.0) 60.4 (47.6, 73.6)
Low- to high-frequency power ratio 0.5 (0.4, 0.7) 0.8 (0.4, 1.5) 0.6 (0.3, 0.7) 0.7 (0.4, 1.2)
Handgrip Low-frequency power (nu) 66.6 (60.2, 73.4) 64.0 (55.4, 75.9) 67.5 (52.9, 80.5) 65.5 (54.9, 78.5)
High-frequency power (nu) 33.4 (26.7, 39.8) 32.5 (22.6, 39.6) 32.5 (19.6, 47.1) 32.5 (21.1, 41.2)
Low- to high-frequency power ratio 2.0 (1.5, 2.7) 1.9 (1.4, 3.1) 2.1 (1.1, 4.2) 1.9 (1.3, 5.0)
Tilt Low-frequency power (nu) 79.9 (67.8, 85.2) 76.0 (67.2, 82.2) 68.8 (59.2, 82.2) 74.5 (66.1, 81.8)
High-frequency power (nu) 20.1 (14.9, 32.3) 24.0 (17.8, 32.9) 31.2 (17.8, 40.8) 25.5 (18.2, 33.9)
Low- to high-frequency power ratio 4.0 (2.1, 5.9) 3.2 (2.0, 4.6) 2.2 (1.5, 4.7) 2.9 (1.9, 4.5)

Note: Data are presented as median (Q1, Q3) deviation for the low-frequency power, high-frequency power, and low- to high-frequency power ratio. A Wilcoxon signed rank test was used to assess the differences between groups.